Skip to main content

Advertisement

SpringerLink
Log in

Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

Increasing the rate of pathological complete remissions after neoadjuvant chemoradiation of rectal cancer has become a strategy to further improve the long-term oncological outcome of patients. This report evaluates the influence of preoperative intensified radiochemotherapy on the rate and outcome of surgical complications.

Materials and Methods

Patients with primary rectal cancer at stages cT3/4cNx or N+ without metastasis were preoperatively treated either with capecitabine and irinotecan or with capecitabine, irinotecan and ceutximab with a concurrent radiation (50.4 Gy). Surgery was scheduled 4–7 weeks after completion of the chemoradiation. Perioperative complications were prospectively documented during the patient’s hospital stay.

Results

Fifty-nine patients (median age 60; male/female: 46/13) undergoing surgery at a single center were analysed. The median distance of the tumour from the dentate line was 5 cm. The operations performed were low anterior resection (n=45), Hartmann’s procedure (n=4) and abdominoperineal resection (n=10). Total mesorectal excision with R0-resection was accomplished in all but one patients. Histopathological regression was described in four grades (0–3) as defined by the Japanese Society for Cancer of the Colon and Rectum. Tumors were called major responsive when assigned to the regression grades 3 or 2, and minor or nonresponsive at regression grades 1 or 0. In total, 33 patients (55.9%) had a regression grade 2 or 3. Among them, 12 patients showed a pathological complete response without any residual cancer cell (20.3%). Seven out of 45 patients (15.5%) with sphincter-preserving surgery suffered from suture breakdown; they all had previously shown a major response of the resected tumor. Two of them died during the hospital stay.

Conclusions

While in general, patients undergoing neoadjuvant intensified treatment suffer from a slight increase in surgical complications, this is markedly enhanced in patients with good treatment responses. Our results underline the oncological benefit of intensified neoadjuvant chemoradiation, but the severity of complications in low rectal anastomosis of patients with good response after neoadjuvant therapy should alert surgeons and oncologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346

    PubMed  CAS  Google Scholar 

  2. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–60

    Article  PubMed  CAS  Google Scholar 

  3. Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–8

    Article  PubMed  Google Scholar 

  4. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ (1997) Abdominoperineal excision of the rectum-an endangered operation. Dis Colon Rectum 40:747–51

    Article  PubMed  CAS  Google Scholar 

  5. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ (1998) Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 85:526–529

    Article  PubMed  CAS  Google Scholar 

  6. Karanija ND, Corder AP, Bearn P, Heald RJ (1994) Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81:1224–1226

    Article  Google Scholar 

  7. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy in rectal cancer. for the German rectal Cancer Study Group N Engl J Med 351:1731–1740

    Article  PubMed  CAS  Google Scholar 

  8. Rödel C, Martus H, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy in rectal cancer. J Clin Oncol 23:8688–8696

    Article  PubMed  Google Scholar 

  9. Janjan NA, Khoo VS, Rich TA, Evetts PA, Goswitz MS, Allen PK, Skibber JM (1998) Locally advanced rectal cancer: Surgical complications after infusional chemotherapy and radiation therapy. Radiology 206:131–136

    PubMed  CAS  Google Scholar 

  10. Crane CH, Skibber J (2003) Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment. Int J Radiat Oncol Biol Phys 21:265–270

    Google Scholar 

  11. Bujko K, Nowacki MP, Nesierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. for the Polish Colorectal Study Group Br J Surg 93:1215–1223

    Article  PubMed  CAS  Google Scholar 

  12. Wong RK, Tandan V, De Silva S, Figueredo A (2007) Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2:CD002102 (online)

  13. Marijnen CAM, Kapiteijn E, van de Velde CJH, Martijn H, Steup WH, Wiggers T, Klein Kranenbarg E, Leer JWH (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a Multicenter randomized trial. the Cooperative Investigators of the Dutch Colorectal Cancer Group J Clin Oncol 20:817–825

    Article  PubMed  CAS  Google Scholar 

  14. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–345

    Article  PubMed  CAS  Google Scholar 

  15. Hofheinz RD, v. Gerstenbergk-Helldorff B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Müldner A, Hehlmann R, Post S, Hochhaus A, Willeke F (2005) Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23:1350–1357

    Article  PubMed  CAS  Google Scholar 

  16. Willeke F, Horisberger K, Kraus-Tiefenbacher U, Wenz F, Leitner A, Hochhaus A, Grobholz R, Willer A, Kähler G, Post S, Hofheinz R (2007) A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer 96:912–917

    Article  PubMed  CAS  Google Scholar 

  17. Hofheinz R, Horisberger K, Woernle C, Wenz F, Kraus-Tiefenbacher U, Kähler G, Dinter D, Grobholz R, Heeger S, Post S, Hochhaus A, Willeke F (2007) Phase I trial of Cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys 66:1384–1390

    Google Scholar 

  18. Z’Graggen K, Maurer CA, Birrer S, Giachino D, Kern B, Buchler MW (2001) A new surgical concept for rectal replacement after low anterior resection: the transverse coloplasty pouch. Ann Surg 234:780–785

    Article  PubMed  CAS  Google Scholar 

  19. UICC (2002) TNM classification of malignant tumours, 6th edn. Sobin LH, Wittekind C (eds) Wiley-Liss, New York

  20. Japanese Society for Cancer of the Colon and Rectum (JSCCR) (1997) Japanese classification of colorectal carcinoma, 1st English edn. Kanehara & Co, Tokyo

  21. Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann Royal Coll Surg Engl 73:385–388

    CAS  Google Scholar 

  22. Alves A, Panis Y, Mathieu P, Kwiatkowski F, Slim K, Mantion G (2005) Mortality and morbidity after surgery of mid and low rectal cancer. Gastroenterol Clin Biol. the Association Francaise de Chirurgie 29:509–514

    PubMed  Google Scholar 

  23. Valero G, Lujan JA, Hernandez Q, de las Heras M, Pellicer E, Serrano A, Parrilla P (2003) Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis 18:495–499

    Article  PubMed  CAS  Google Scholar 

  24. Hilsabeck JR (1982) The presacral space as a collector of fluid accumulations following rectal anastomosis: tolerance of rectal anastomosis to closed suction pelvic drainage. Dis Colon Rectum 25:680–684

    Article  PubMed  CAS  Google Scholar 

  25. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand S, Deutsch M, Wickerham L, Fisher B, Wolmark N (1997) A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. Dis Colon Rectum 40:131–139

    Article  PubMed  CAS  Google Scholar 

  26. Luna-Perez P, Rodriguez-Ramirez S, Hernandez-Pacheco F, Gutierrez de la Barrera M, Fernandez R, Labastida S (2003) Anal sphincter preservation on locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. J Surg Oncol 82:3–9

    Article  PubMed  Google Scholar 

  27. Chao M, Gibbs P, Tjandra J, Cullinan M, McLaughlin S, Faragher I, Skinners I, Jones I (2005) Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer. ANZ J Surg 75:286–291

    Article  PubMed  Google Scholar 

  28. Mohiuddin M, Winter K, Mitchel E, Nader H, Yuen A, Nichols C Shane R, Hayostek C, Willet C (2006) Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: radiation therapy oncology group trial 0012. J Clin Oncol 24:650–655

    Article  PubMed  CAS  Google Scholar 

  29. Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M (1998) Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 85:355–358

    Article  PubMed  CAS  Google Scholar 

  30. Matthiessen P, Hallböök O, Andersson M, Rutegard J, Sjödahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorect Dis 6:462–469

    Article  CAS  Google Scholar 

  31. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, Barbet N, Atlan D, Adeleine P, Freyer G (2003) Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and Oxaliplatin-containing regimen: The Lyon R0–04 phase II trial. J Clin Oncol 21:1119–1124

    Article  PubMed  Google Scholar 

  32. Pucciarelli S, Toppan P, Friso ML, Fornasiero A, Vieceli G, Marchiori E, Lise M (1999) Preoperative combined radiotherapy and chemotherapy for rectal cancer does not affect early postoperative morbidity and mortality in low anterior resection. Dis Colon Rectum 42:1276–1284

    Article  PubMed  CAS  Google Scholar 

  33. Mehta VK, Poen J, Ford J, Edelstein PS, Vierra M, Bastidas AJ, Young H, Fisher G (2001) Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 44:52–58

    Article  PubMed  CAS  Google Scholar 

  34. Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R (2005) Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92:1215–20

    Article  PubMed  CAS  Google Scholar 

  35. Johnson LB, Jorgensen LN, Adawi D, Blomqvist P, Asklöf GB, Gottrup F, Jeppsson B (2005) The effect of preoperative radiotherapy on systemic collagen disposition and postoperative infective complications in rectal cancer patients. Dis Colon Rectum 48:1573–1580

    Article  PubMed  Google Scholar 

  36. Tran CL, Udani S, Holt A, Arnell T, Kumar R, Stamos MJ (2006) Evaluation of safety of increased time interval between chemoradiation and resection of rectal cancer. Am J Surg 192: 873–877

    Article  PubMed  Google Scholar 

  37. Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG (2004) Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47:279–286

    Article  PubMed  Google Scholar 

  38. Kundel Y, Brenner B, Symon Z, Oberman B, Sadezki S, Koller M, Catane R, Pfeffer R (2007) A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Anticancer Res 27:2877–80

    PubMed  CAS  Google Scholar 

  39. Lay GC, Caraul B, Dessi M, Orru S, Murtas R, Derrida MA, Fariqu R, Farci D, Maxia L, Casula G, Amichetti M (2007) Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma. J Exp Clin Cancer Res 26:61–70

    PubMed  CAS  Google Scholar 

  40. Machiels JP, Sempoux C, Scalliet P, Coche JC, Humblet Y, Van Cutsem E, Kerger J, Canon JL, Peeters M, Aydin S, Laurent S, Kartheuser A, Coster B, Roels S, Daisne JF, Honhon B, Duck L, Kirkove C, Bonny MA, Haustermans K (2007) Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol 18:738–744

    Article  PubMed  Google Scholar 

  41. Hospers GA, Punt CJ, Tesselaar ME, Cats A, Havenga K, Leer JW, Marijnen CA, Jansen EP, Van Krieken HH, Wiggers T, Van de Velde CJ, Mulder NH (2007) Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group. Ann Surg Oncol 14:2773–2779

    Article  PubMed  Google Scholar 

  42. Engelen SM, Beets GL, Beets-Tan RG (2007) Role of preoperative local and distant staging in rectal cancer. Onkologie 30:141–145

    Article  PubMed  Google Scholar 

  43. Stein DE, Mahmoud NN, Anne PR, Rose DG, Isenberg GA, Goldstein SD, Mitchell E, Fry RD (2003) Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 46:448–453

    Article  PubMed  Google Scholar 

  44. Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987

    Article  Google Scholar 

  45. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJT, Pahlman L, Glimelius B, van Krieken HJM, Leer JWH, van de Velde CJH (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. for the Dutch Colorectal Cancer Group N Engl J Med 345:638–646

    Article  PubMed  CAS  Google Scholar 

  46. Peeters KCMJ, van de Velde CJH, Leer JWH, Martijn H, Junggeburt JMC, Klein Kranenbarg E, Steup WH, Wiggers T, Rutten HJ, Martijnen CAM (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23:6199–6206

    Article  PubMed  CAS  Google Scholar 

  47. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. Swedish Rectal Cancer Trial Group. J Clin Oncol 23:8697–8705

    Article  Google Scholar 

  48. Tsujinaka S, Kawamura YJ, Konishi F, Aihara H, Maeda T, Mizokami K (2008) Long-term efficacy of preoperative radiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 23:67–76

    Article  PubMed  Google Scholar 

  49. Bell SW, Walker KG, Rickard MJFX, Sinclair G, Dent OF, Chapuis PH, Bokey EL (2003) Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg 90:1261–1266

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University Hospital Mannheim, Mannheim, Germany

    K. Horisberger, P. Palma, A. K. Volkert, S. Rothenhoefer, S. Post & F. Willeke

  2. Department of Clinical Oncology, University Hospital Mannheim, Mannheim, Germany

    R. D. Hofheinz & A. Hochhaus

  3. Institute of Radiation Therapy, University Hospital Mannheim, Mannheim, Germany

    F. Wenz

  4. Department of Surgery, Marienkrankenhaus Siegen, Siegen, Germany

    F. Willeke

  5. Chirurgische Klinik, Universitätsklinik Mannheim, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany

    K. Horisberger

Authors
  1. K. Horisberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. D. Hofheinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Palma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. K. Volkert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Rothenhoefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Wenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Hochhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Post
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Willeke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Horisberger.

Additional information

R.D. Hofheinz contributed equally with K. Horisberger to the study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horisberger, K., Hofheinz, R.D., Palma, P. et al. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?. Int J Colorectal Dis 23, 257–264 (2008). https://doi.org/10.1007/s00384-007-0408-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-007-0408-6

Keywords

Search

Navigation